Nilakshi N. Dhoble*, Snehal H. Gawai, Rashmi G. Khope and Jagdish R. Baheti


Recently, drug delivery using biological carriers has emerged as one of the most recent topics of research. Approach of using synthetic nanoparticles (NPs) and erythrocytes combination strategy offers an optimal blend of natural and synthetic materials. This combination strategy could serve as an immune-evasive multifunctional platform. This review summarized significant advances in erythrocytes based nanomedicine targeted drug delivery, and included their fabrication process, their unique properties and applications. Erythrocytes or red blood cells, can act as potential carriers for a wide variety of drugs, including analgesic, anticancer, antibacterial, antiviral, and anti-inflammatory, peptides, enzymes, and other macromolecules. Human red blood cells (RBC), after differentiating from erythroblasts in the bone marrow, are released into the blood and survive in the circulation for approximately 115 days. Erythrocytes having a remarkable bio-compatibility, bio-degradability, and life-span in circulation; makes it a desirable vector for the delivery of the drug as nanomedicine. The erythrocytes based nanomedicine is generally synthesized by either physical or chemical methods by incorporating a wide spectrum of therapeutic agents in the form of nanoparticles. In the current scenario, erythrocyte based nanomedicine holds a great potential of the targeting of drug for therapeutic uses and can also be used for the diagnosis of the human diseases. This review focuses on the most recent advancements in the field of erythrocytes based targeted drug delivery and as an excellent and promising nano platform for the novel targeted drug delivery of various drugs especially antineoplastic and thrombolytic drugs along with their potential as a promising diagnostic tool for the identification of different tumors.

Keywords: Erythrocyte, Nanomedicine, Targeted Drug Delivery, immune-evasive.

[Full Text Article]   [Download Certificate]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation


    JUNE 2024 Issue has been successfully launched on 1 JUNE 2024.

  • EJBPS New Impact Factor

    EJBPS Impact Factor has been Increased to 7.482 for Year 2024.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction